ImmunoGen Message Board - Msg: 31545254

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 3:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gary Mohilner who wrote (5596)	3/27/2018 10:30:07 AM
From: JamesK	Read Replies (1) of 5665

There were only 8 patients in the target group so I don't see much hope of approval on that. They are moving that into a 35 patient trial. It probably wouldn't enroll and get results till the Forward I is due anyway. Pricing in a combo is a worry. Both companies will want top dollar for their part of the combo. They are progressing though and the share price has moved up accordingly..

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next